Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelomonocytic Leukemia

Explore clinical trials studying Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

191 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelomonocytic Leukemia trial results

Completed

Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia

NCT01251627

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +12 more
Locations
  • Ematologia, Ospedale SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • AOU Ospedali Riuniti di Ancona Ancona, Italy
  • Ematologia AOU Policlinico di Bari Bari, Italy
  • Istituto di Ematologia e Oncologia Medica, Policlinico S.Orsola Bologna, Italy
View all 21 locations
View Trial Details
Completed

Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT01757639

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Yale-New Haven Hospital North Haven Medical Center North Haven, Connecticut, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

NCT01101880

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +27 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00118352

Conditions
Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Torino Torino, Italy
View Trial Details

Related conditions